Capital expenditure increased 47.0%
Capital expenditure changed +47.0% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +47.0% from the comparable as-filed period.
Cash & equivalents changed -21.7% from the comparable as-filed period.
Free-cash-flow proxy changed +79.3% from the comparable as-filed period.
Net income changed +11425.9% from the comparable as-filed period.
Operating cash flow changed +100.6% from the comparable as-filed period.
Debt changed -19.1% from the comparable as-filed period.
Gross margin changed +290 basis points from the comparable as-filed period.
Inventory changed +14.0% from the comparable as-filed period.
Operating income changed +18.8% from the comparable as-filed period.
Operating margin changed +282 basis points from the comparable as-filed period.
Capex / revenue changed +131 basis points from the comparable as-filed period.
Gross profit changed +6.5% from the comparable as-filed period.
Research & development changed -8.6% from the comparable as-filed period.
Revenue changed +2.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.